Spain· ES:1171174002
ROLUFTA ELLIPTA 55 MICROGRAMOS POLVO PARA INHALACION (UNIDOSIS)
A medicinal product containing bromuro umeclidinio, registered in Spain by Glaxosmithkline Trading Services Limited.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- bromuro umeclidinio
- Manufacturer
- Glaxosmithkline Trading Services Limited
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cima_codigo72240730EUR 45.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Bromuro umeclidinio in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaINCRUSE ELLIPTAGlaxoSmithKline Trading Services Limited, Dublin
- BelgiumIncruse Ellipta 55 µgGlaxoSmithKline Trading Services
- FinlandIncruse ElliptaParanova Oy
- SwedenIncruse Ellipta 55 mikrogram Inhalationspulver, avdelad dosGlaxoSmithKline Trading Services Ltd
- IrelandIncruse Ellipta 55 micrograms inhalation powder, pre-dispensedGlaxoSmithKline Trading Services Limited
- NetherlandsIncruse Ellipta 55 microgram inhalatiepoeder, voorverdeeldGlaxoSmithKline Trading Services Limited
- PolandIncruse ElliptaGlaxoSmithKline (Ireland) Limited
- SwitzerlandIncruse Ellipta
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Incruse Ellipta, Rolufta Ellipta
- Liechtenstein · Incruse Ellipta, Rolufta Ellipta
- Norway · Incruse Ellipta, Rolufta Ellipta
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e05d8c66-0793-4b85-892d-f33a15f7b2c1 GET /v1/drugs/e05d8c66-0793-4b85-892d-f33a15f7b2c1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Medicamento Sujeto A Prescripción Médica",
"estado": "{\"aut\":1533074400000}",
"nregistro": "1171174002",
"substance": "bromuro umeclidinio"
}See everything about bromuro umeclidinio.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.